Description
SPECIALIZED ANATOMIC PATHOLOGY TESTING
First action · last action
2012-11-27 · 2014-07-18
Transactions
2
First transaction's obligation
$280,000
Base + all options value (sum of deltas)
$268,857
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2086D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-11-27+$280,000= $280,000
- Mod P000012014-07-18-$11,143= $268,857
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-11-27 | +$280,000 | $280,000 | SPECIALIZED ANATOMIC PATHOLOGY TESTING |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2014-07-18 | −$11,143 | $268,857 | SPECIALIZED ANATOMIC PATHOLOGY TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI X2XMAQLR9DA8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79724A0018 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C26124N0260 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $11,882 | FY2024 |
| 36C26023F0186 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $144,553 | FY2023 |
| 36C26223F0045 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $246,001 | FY2023 |
| 36C26223F0022 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $266,652 | FY2023 |
| 36C26222F0606 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $20,049 | FY2022 |
Other recipients under 6515 from 642-PHILADELPHIA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24415P6722 | LAWALL PROSTHETICS ORTHOTICS INC | 642-PHILADELPHIA | $5,481 | FY2015 |
| VA24415F5912 | HOWMEDICA OSTEONICS CORP | 642-PHILADELPHIA | $6,519 | FY2015 |
| VA24415P4128 | MCKESSON SPECIALTY DISTRIBUTION LLC | 642-PHILADELPHIA | $1,660 | FY2015 |
| VA24415P2523 | ROCHE DIAGNOSTICS CORPORATION | 642-PHILADELPHIA | $23,328 | FY2015 |
| VA24415P1622 | AMERICAN PURCHASING SERVICES, LLC | 642-PHILADELPHIA | $11,250 | FY2015 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24413F0534_3600_V797P2086D_3600 · retrieved 2026-09-26.